Jupiter International commissioned its third solar cell manufacturing facility in Baddi, Himachal Pradesh. With this expansion, the company marks a significant milestone in its capacity scaling strategy and strengthens its position in India’s fast-growing renewable energy sector. The facility has been developed through its subsidiary, Jupiter Solartech, reinforcing the group’s integrated solar manufacturing roadmap.

Capacity Expansion: Total Output Nears 2 GW

The newly commissioned Unit-III adds 1 GW of mono PERC solar cell capacity to Jupiter’s existing 959 MW production base. As a result, the company’s total installed capacity now stands at nearly two GW. The plant focuses on high-efficiency mono PERC (Passivated Emitter and Rear Cell) technology. This technology delivers improved energy conversion efficiency and aligns with global quality and productivity benchmarks. Moreover, the expansion positions Jupiter to cater to rising domestic and international demand for high-performance solar cells.

Technology Roadmap: 1.25 GW TOPCon Line Under Development

In addition to scaling mono PERC production, Jupiter is accelerating its transition toward next-generation solar technologies. The company is currently setting up a 1.25 GW TOPCon (Tunnel Oxide Passivated Contact) solar cell manufacturing line. By investing in advanced TOPCon technology, Jupiter aims to enhance cell efficiency, reduce energy losses, and future-proof its manufacturing portfolio against evolving global standards.

Commitment to Clean Energy Growth

Alok Garodia, Chairman and Managing Director of Jupiter International, emphasised the strategic importance of the new unit. He described the commissioning of Unit-III at Baddi as a major milestone in the company’s journey to scale solar manufacturing capabilities. He further stated that the expansion reinforces Jupiter’s long-term vision of delivering world-class clean energy technologies and supporting India’s renewable energy transition.

Strengthening India’s Solar Manufacturing Ecosystem

As reported by projectstoday.com, overall, the commissioning of the third unit reflects Jupiter International’s commitment to scaling high-efficiency solar cell production in India. By combining mono PERC capacity expansion with upcoming TOPCon technology investments, the company is positioning itself as a competitive player in both domestic and global solar markets.

Alkem Medtech announced plans to acquire up to 55 percent stake in Swiss medical devices company Occlutech Holding AG for €99.4 million (approximately ₹1,074 crore). The transaction, subject to statutory and regulatory approvals, marks Alkem’s formal entry into the advanced cardiovascular devices segment. Alkem Medtech, a wholly owned subsidiary of Alkem Laboratories, has executed a binding offer for the majority stake. The acquisition is expected to close by June 2026, following regulatory clearances and fulfilment of customary conditions, including foreign investment approvals in certain jurisdictions.

Strategic Entry into Advanced Cardiovascular Devices

With this acquisition, Alkem Medtech will expand into high-value, minimally invasive cardiac implant technologies. Occlutech develops, manufactures, and commercialises devices used in treating congenital heart disease, stroke prevention, and heart failure.

Notably, Occlutech ranks as the second-largest company in Europe and the third-largest globally in the minimally invasive cardiac implants segment. The company operates:

*Manufacturing and R&D facilities in Germany and Turkey

*A global distribution hub in Sweden

*Clinical operations in the United States

Through this footprint, Occlutech has built a strong presence in regulated and innovation-driven markets.

Building a Global MedTech Platform

BN Singh, Executive Chairman of Alkem Laboratories, emphasised the long-term strategic vision behind the move. He stated that the acquisition reinforces Alkem’s ambition to become a global player in medical devices. It aims to replicate the success the company has achieved in pharmaceuticals.

Kaustav Banerjee, CEO of Alkem Medtech, highlighted Occlutech’s strengths in structural heart devices, experienced leadership, world-class R&D and manufacturing capabilities, and a strong quality and regulatory framework. He noted that these capabilities provide a solid foundation for Alkem’s expansion into cardiology and enable sustainable long-term growth.

Tor Peters, CEO of Occlutech, said that over the past 23 years, the company has built a patient-centric and innovation-driven organisation. He added that these values align closely with Alkem’s growth strategy.

MedTech: A Natural Extension of Alkem’s Growth Strategy

Sandeep Singh, Managing Director of Alkem Laboratories, described MedTech as a natural extension of the company’s pharmaceutical business. He added that alongside Enzene Biosciences, Alkem’s biotech arm, Alkem Medtech is expected to emerge as a meaningful growth pillar in the coming years.

Outlook

Overall, the proposed acquisition signals Alkem’s strategic diversification beyond pharmaceuticals into high-growth medical devices. As reported by thehindubusinessline.com, the company plans to combine Occlutech’s technological expertise with Alkem’s scale and global reach. Through this strategy, it aims to build a strong foothold in advanced cardiovascular care and position itself as an emerging global MedTech player.

Numaligarh Refinery Limited (NRL) announced that its ambitious Refinery Expansion Project, along with the 1,635-km Paradip–Numaligarh Crude Oil Pipeline and the Crude Oil Import Terminal at Paradip, is expected to be completed by December 2026. The integrated expansion marks a significant milestone in strengthening energy infrastructure in Northeast India.

Capacity Expansion from 3 MMTPA to 9 MMTPA

NRL is tripling its refining capacity from three MMTPA to nine MMTPA, reinforcing its role as a key fuel supplier in the region. To support the enhanced capacity, the company is laying a 1,635-km crude oil pipeline from Paradip Port in Odisha to Numaligarh in Assam. The strategic pipeline will ensure stable and efficient crude sourcing while reducing logistical constraints. Once operational, the expanded refinery and dedicated pipeline network will significantly improve feedstock security and operational efficiency.

Paradip Crude Oil Import Terminal Strengthens Supply Chain

In addition to the refinery upgrade, NRL is developing a Crude Oil Import Terminal at Paradip. This facility will enhance crude handling capabilities and streamline imports, thereby improving supply chain resilience. Together, the refinery expansion, pipeline, and import terminal form an integrated energy corridor connecting eastern India to the Northeast.

2G Biorefinery Commissioned with Carbon-Negative Impact

NRL has already commissioned its 2G (second-generation) biorefinery, which will deliver a carbon-negative environmental impact. The project aligns with India’s clean energy and biofuel goals, promoting sustainable fuel production from biomass while reducing greenhouse gas emissions. In September 2025, the Prime Minister inaugurated the Assam Bioethanol Plant and laid the foundation stone for a new polypropylene plant at NRL’s complex in Golaghat, Assam.

Polypropylene Plant to Boost Petrochemical Output

As part of its downstream diversification strategy, NRL will set up a 360 KTPA polypropylene plant at an estimated project cost of over ₹7,000 crore. Once completed, the polypropylene unit — along with the expanded refinery — will increase NRL’s Petrochemical Intensity Index by 4.0, significantly strengthening its petrochemical portfolio. The move positions NRL not just as a fuel producer but also as an emerging petrochemical player in the region.

Strategic Impact on Northeast Energy and Industrial Growth

The combined projects are expected to:

*Enhance India’s energy security

*Strengthen crude supply logistics to Assam

*Boost petrochemical production capacity

*Support regional industrial development

*Generate employment and economic growth in the Northeast

As reported by etenergyworld.com, with completion targeted for December 2026, Numaligarh Refinery’s expansion represents one of the most significant energy infrastructure upgrades in eastern India.

Rashtriya Chemicals and Fertilizers Ltd (RCFL) announced plans to invest ₹865 crore to set up a new phosphoric acid facility in Maharashtra. With this strategic investment, the company aims to strengthen raw material security and enhance its integrated fertilizer operations.

Strengthening Raw Material Security for DAP and NPK Production

The proposed plant will significantly improve RCF’s access to phosphatic inputs, which are critical for producing complex fertilizers such as DAP (Di-Ammonium Phosphate) and NPK grades.

By expanding in-house phosphoric acid production, RCF intends to:

*Reduce dependence on imports

*Improve supply chain stability

*Optimize operational costs

*Enhance production efficiency

As global fertilizer markets remain volatile, this backward integration strategy will help the company ensure greater control over key raw materials.

Aligning with India’s Fertilizer Self-Reliance Goals

The project aligns with the government’s broader objective of boosting domestic fertilizer manufacturing capacity. By increasing local production of essential nutrients, the initiative supports the goal of ensuring consistent fertilizer availability for India’s agricultural sector. Maharashtra continues to serve as a strategic hub for RCF’s operations. In particular, the company’s Thal unit plays a central role in its production network, making the location ideal for capacity expansion.

Boosting Agricultural Productivity and Regional Growth

Once commissioned, the new phosphoric acid facility is expected to:

*Strengthen agricultural productivity by ensuring steady nutrient supply

*Enhance value addition within RCF’s integrated operations

*Support regional industrial development

*Generate employment opportunities

The sale of a seventy-nine percent stake in Wellbeing Nutrition to Mumbai-based pharmaceutical major USV for ₹1,583 crore is not a founder exit, but a strategic move to scale within a pharmaceutical ecosystem, according to Founder and CEO Avnish Chhabria. Chhabria emphasized that the partnership represents validation from mainstream pharma.

“Not a Cash-Out, But a Strategic Scale-Up”

Chhabria said the deal marks a long-term growth collaboration rather than an exit. “This is not us cashing out. This is an entrance into a world that traditionally did not take nutraceutical brands seriously.” He continues to hold 15% stake in the company, while the remaining 6% is held by Co-founder Saurabh Kapoor and ESOP holders. According to Chhabria, the leadership team remains fully committed to scaling Wellbeing Nutrition within the USV ecosystem.

USV Expands into Preventive and Lifestyle Healthcare

With this acquisition, USV — a leading player in India’s oral anti-diabetes and cardiac segments — expands beyond chronic therapies into the fast-growing preventive and lifestyle healthcare space. The move reflects a broader shift in India’s pharmaceutical landscape, where established drugmakers are increasingly exploring wellness and nutraceutical brands to diversify portfolios and tap into rising consumer health awareness.

Strong Revenue Growth and Profitability Roadmap

Founded in 2019, Wellbeing Nutrition has scaled rapidly. The company expects to close FY26 with revenue of approximately ₹263 crore, up sharply from ₹112 crore in the previous year. Looking ahead, it is targeting ₹450 crore in revenue next year, signaling aggressive growth plans under the new partnership. Importantly, nearly 15% of its revenue comes from prescription and hospital channels — a rare distinction in the largely D2C-driven nutraceutical market. This pharma-style distribution approach strengthens its credibility and medical acceptance. Chhabria also highlighted that the company is unit-economics positive and expects to turn fully profitable over the next year.

R&D-Driven Premium Positioning

Operating in the premium segment, Wellbeing Nutrition maintains an average order value of around ₹2,500. It follows an omnichannel strategy, combining direct-to-consumer (D2C), pharmacy sales, and modern trade distribution. The company currently has a presence in over 6,500 retail outlets across India. At the same time, it has begun expanding internationally, particularly in West Asia and Europe. To strengthen product differentiation, Wellbeing Nutrition has invested over ₹60 crore in research and development.

The investment has enabled the development of proprietary delivery formats such as:

*Oral thin strips

*Delayed-release capsules

Such innovations position the brand at the intersection of science-backed nutrition and consumer convenience.

Rising Consolidation in Consumer Health

The transaction underscores increasing consolidation in India’s consumer health and wellness market. As growth in preventive healthcare accelerates, traditional pharmaceutical companies are actively acquiring high-growth nutraceutical brands to capture emerging demand. As reported by thehindubusinessline.com, for Wellbeing Nutrition, the partnership with USV signals more than capital infusion — it represents pharma validation, distribution strength, and a platform for sustained long-term growth.

Surat-based Acutaas Advance Material Ltd, formerly known as Baba Advance Materials Ltd and a wholly owned subsidiary of Acutaas Chemicals Ltd, successfully acquired a 75% controlling stake in South Korea-based Indichem Inc. With this move, the company formally enters the high-growth semiconductor chemicals manufacturing sector in South Korea. The acquisition, executed under a previously signed joint venture (JV) agreement, marks a significant milestone in Acutaas’ global expansion strategy.

Indichem Becomes Step-Down Subsidiary

Following the completion of the transaction, Indichem Inc officially become a step-down subsidiary of Acutaas Chemicals Ltd, the company confirmed in a regulatory filing. The company stated that Acutaas Advance Material Ltd acquired 75% shareholding rights in Indichem in accordance with the executed JV agreement. With this, the acquisition of the controlling stake now stands completed.

Transaction Details and Investment Structure

Acutaas executed the transaction through a cash purchase of 300,000 shares, each at a par value of KRW 500, along with applicable share premium. Indichem Inc, incorporated in 2025, operates in the semiconductor chemicals segment — a sector witnessing strong global demand amid rapid expansion in chip manufacturing capacity. Meanwhile, construction and capital expenditure (capex) work at Indichem’s manufacturing facility in South Korea is progressing steadily. The company expects to commission the plant by the end of the current calendar year.

Strategic Expansion into Semiconductor Chemicals

The acquisition strengthens Acutaas’ international footprint and positions it within the fast-growing semiconductor supply chain ecosystem. As global chipmakers continue to expand capacity, demand for high-purity and specialty semiconductor chemicals is rising significantly. By establishing a manufacturing presence in South Korea — one of the world’s leading semiconductor hubs — Acutaas aims to leverage regional demand and build long-term partnerships with chip manufacturers.

Management Commentary: Strong Traction and Revenue Visibility

Naresh Patel, Chairman and Managing Director of Acutaas Chemicals, said the company is witnessing encouraging traction from customers. Initial discussions are already underway with multiple potential clients across South Korea, Japan, and Taiwan. Highlighting the scale of investment, Abhishek Patel, Vice President (Strategy), Acutaas Chemicals, stated that the company has invested approximately ₹130 crore in the South Korea joint venture so far. The total announced investment for the project stands at around ₹200 crore. He further added that Acutaas has sufficient cash reserves and strong operating cash flows to fund the remaining outlay. Importantly, once the capex is completed in 2026, the company expects to begin generating revenue from the Indichem project starting next calendar year.

Outlook: Strengthening Global Semiconductor Chemicals Footprint

As reported by thehindubusinessline.com, with this acquisition, Acutaas Chemicals accelerates its transition into advanced semiconductor chemicals manufacturing. As the South Korean facility moves toward commissioning, the company expects revenue contributions from 2026 onward. This will reinforce its global growth ambitions. The move signals Acutaas’ intent to become a meaningful player in the international semiconductor chemicals value chain.

Anupam Rasayan India Ltd., a custom synthesis and specialty chemicals company, announced its consolidated financial results for the quarter ended December 31, 2025. The company delivered solid year-on-year growth, driven by robust demand and strategic expansion initiatives.

Q3 FY26 Consolidated Financial Highlights

Anupam Rasayan reported total revenue of ₹5,145 million in Q3 FY26, compared to ₹3,866 million in Q3 FY25. This marks an impressive 33% year-on-year growth, reflecting strong execution across key business segments.

EBITDA Maintains Healthy Margin

EBITDA (including other income) stood at ₹1,296 million in Q3 FY26, up 7% from ₹1,208 million in the corresponding quarter last year. Despite input cost dynamics, the company maintained a healthy EBITDA margin of 25.20%, underlining operational efficiency and cost discipline.

Profit After Tax Grows 12%

Profit After Tax (PAT) increased to ₹606 million, compared to ₹542 million in Q3 FY25, registering a 12% YoY growth. The improvement in profitability highlights steady margin performance and business momentum.

Nine-Month FY26 Performance Highlights

For the nine months ended December 31, 2025, Anupam Rasayan achieved consolidated revenue of ₹17,297 million. During the same period, EBITDA reached ₹4,024 million, reflecting sustained year-on-year growth and consistent operational performance.

Strategic Expansion: Acquisition of Jayhawk Fine Chemicals

In a significant strategic move, Anupam Rasayan signed a definitive agreement to acquire Jayhawk Fine Chemicals Corporation (USA). This acquisition marks a key milestone in the company’s global growth strategy.

By acquiring Jayhawk, Anupam Rasayan will:

*Strengthen its presence in the United States

*Enhance advanced custom synthesis capabilities

*Expand access to regulated markets

*Deepen relationships with innovator customers in North America

This development positions the company to accelerate its transformation into a global specialty chemical platform.

Management Commentary

Anand Desai, Managing Director, said, “I am pleased to share that for the nine months of FY26, we delivered consolidated revenue of ₹17,297 million with EBITDA of ₹4,024 million, reflecting strong year-on-year growth. For Q3 FY26, revenue stood at ₹5,124 million with EBITDA of ₹1,296 million, demonstrating continued growth momentum. A significant strategic development during the period has been the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States. This acquisition strengthens our global footprint, enhances our capabilities in advanced custom synthesis, and deepens our access to regulated markets and innovator customers in North America. It represents an important step in our journey toward becoming a global specialty chemical platform.”

Outlook

As per the press release, with steady financial growth and a strategic international acquisition underway, Anupam Rasayan continues to reinforce its position as a leading player in the global specialty chemicals and custom synthesis industry.

Zuari Industries Limited announced its unaudited financial results for the quarter ended December 31, 2025, delivering steady operational performance across key business segments.

On a standalone basis, the company reported:

*Total Revenue: ₹254.7 crore in Q3 FY26

*Revenue (9M FY26): ₹727.6 crore

*EBITDA: ₹36.3 crore for the quarter; ₹125.7 crore for nine months

*Profit Before Tax (before exceptional items): ₹4.5 crore in Q3 FY26; ₹24.0 crore in 9M FY26

*The performance reflects disciplined cost management and operational stability during the period.

Consolidated Performance Shows Profitability Improvement

On a consolidated basis:

*Total Revenue: ₹301.5 crore in Q3 FY26

*Revenue (9M FY26): ₹855.6 crore

*Profit After Tax (Q3 FY26): ₹(26.4) crore versus ₹(25.2) crore in Q3 FY25

*Profit After Tax (9M FY26): ₹137.4 crore compared to ₹(73.6) crore in the corresponding period last year

Importantly, the company benefited from a reduction in its average borrowing cost, which supported overall financial discipline and strengthened its balance sheet position.

Sugar, Power and Ethanol Division Delivers Record Crushing

The Sugar, Power and Ethanol (SPE) division demonstrated strong operational momentum. Crushing operations commenced on 26 October 2025, marking the earliest-ever start for the company.

Key highlights include:

*Highest-ever Q3 crush: 67.28 lakh quintals

*Sugar production growth: Up 13.7% YoY

*Ethanol production growth: Up 4.8% YoY

*Average sugar realization: Improved 5.9% YoY in Q3 FY26

These gains underscore improved preparedness, operational efficiency, and stronger market realizations during the quarter.

EPCM Business Expands Order Book

Simon India Limited, the group’s EPCM arm, commissioned the fifth Evaporator project for Paradeep Phosphates Limited and is currently executing projects worth approximately ₹100 crore. Additionally, the company continues to deepen domain expertise through partnerships with global technology licensors and research institutions. At the same time, it is investing in AI-driven in-house solutions, positioning itself at the forefront of digital transformation in the EPC sector.

Management Commentary

Athar Shahab, Managing Director, Zuari Industries Ltd., said the third quarter reflected steady operational progress across the Sugar, Power & Ethanol division, supported by strong execution during the crushing season. He highlighted the earliest-ever crushing start and record Q3 performance as indicators of improved operational preparedness. Ethanol operations remained stable, while lower borrowing rates and reduced finance costs strengthened financial discipline.

He further noted that the real estate business is nearing completion of The St. Regis Residences, Dubai project, while the EPCM arm continues to expand execution capabilities and build a strong order pipeline. In financial services, the company remains focused on customer-centric platform enhancements. The successful commissioning of the 180 KLPD bioethanol plant marks a key milestone in the company’s bioenergy journey.

Outlook

As per the press release, Zuari Industries remains focused on strengthening its core businesses while pursuing growth opportunities across sugar, bioenergy, real estate, EPCM, and financial services. With operational efficiencies improving and borrowing costs declining, the company aims to deliver sustainable, long-term value for its stakeholders.

Pahal Solar has expanded its solar module production capacity to 3 GW by integrating operations across unit 1 and unit 2. The expansion marks a significant milestone in the company’s growth strategy and reinforces its commitment to supporting the country’s clean energy transition. As one of the key suppliers under the PM Surya Ghar Yojana, the company is now better positioned to meet rising demand. It will supply reliable, high-quality solar modules. It will serve residential, commercial, and utility-scale projects more efficiently.

ALMM Approval Strengthens Market Access

The expanded capacity has received official approval under the Approved List of Models and Manufacturers (ALMM), as per the latest update dated 7 February 2026 (Registration No. R-72015008). The approval allows Pahal Solar to participate in government-backed and public-sector solar projects, where ALMM compliance remains mandatory. As a result, the company gains broader market access while strengthening customer confidence.

BIS 2023 Certification Ensures Quality and Safety

At the same time, the company’s solar modules fully comply with the Bureau of Indian Standards (BIS) 2023 standards. These certifications confirm adherence to strict benchmarks for quality, safety, and performance laid down by the Government of India. Together, ALMM and BIS approvals position Pahal Solar among the country’s most compliant and dependable module manufacturers.

Ready to Serve Large-Scale Solar Projects

With 3 GW of installed capacity, the company can now ensure:

*Faster order fulfilment

*Reliable supply chains

*Consistent product quality

*Support for large utility-scale projects

*Readiness for government and commercial tenders

Consequently, Pahal Solar can efficiently cater to expanding domestic demand while strengthening India’s push for self-reliance in solar manufacturing.

Leadership Speaks

Paresh Shingala, Chairman and Managing Director of Pahal Solar, said, “The expansion to 3 GW, along with ALMM approval and BIS 2023 certification, reflects our strong focus on quality, scalability, and self-reliance. We are proud to contribute to India’s renewable energy ambitions by delivering dependable and compliant solar solutions manufactured within the country.”

Focus on Technology, Sustainability and Local Value

Bondada Engineering Limited signed a Memorandum of Understanding (MoU) with Bryanston Renewables FZCO, Dubai, to jointly develop green-powered data centre solutions across Bharat and select international markets. The agreement, signed on February 11, 2026, aims to meet the rapidly rising demand for energy-efficient data centres by integrating renewable energy with next-generation digital infrastructure.

Focus on Renewable-Powered Data Infrastructure

Under the MoU, both companies will collaborate to design, develop, and deploy comprehensive data centre project packages powered entirely by green energy. These turnkey solutions will serve domestic and global investors, as well as data centre operators seeking low-carbon, sustainable infrastructure. By combining clean energy with digital ecosystems, the partnership directly supports Bharat’s fast-growing data economy while addressing environmental concerns tied to rising energy consumption.

Meeting Bharat’s Surging Digital Demand

As cloud adoption, digital services, and domestic data storage requirements surge, Bharat’s data centre market continues to expand at an unprecedented pace. However, this growth also increases power demand and carbon footprints. Recognising this challenge, BEL is positioning itself to deliver future-ready, energy-efficient facilities that balance performance with sustainability. The company plans to leverage its strengths across renewable energy, telecom infrastructure, and engineering to create integrated green data centre ecosystems.

Bondada Raghavendra Rao, Chairman and Managing Director, Bondada Group, said, “Bharat’s digital economy is expanding rapidly, driven by rising data consumption and cloud adoption. This creates an urgent need for energy-efficient and future-ready data centre infrastructure. Through this partnership, we aim to deliver green-powered solutions that support both digital growth and long-term sustainability.”

Driving Digital and Energy Transition

R Sreenivas, CEO, Bondada Group, noted, “The partnership marks an important milestone in our journey to contribute to Bharat’s digital and energy transition. By combining renewable energy with next-generation digital infrastructure, we are committed to building sustainable solutions that create long-term value for communities and stakeholders.”

Strategic Entry into a High-Growth Segment

As reported by apnnews.com, the collaboration marks BEL’s strategic expansion into the fast-growing digital infrastructure sector. At the same time, it reinforces the company’s broader commitment to sustainable engineering and clean energy adoption. As demand for low-carbon data centres rises worldwide, the BEL–Bryanston partnership positions both companies to capture new opportunities while supporting Bharat’s clean energy and digital transformation goals.